Age-specific determinants of stunting in Filipino children

L S Adair1, D K Guilkey

  • 1Carolina Population Center, University of North Carolina at Chapel Hill, 27516, USA.

The Journal of Nutrition
|February 1, 1997
PubMed

Insights

Childhood stunting in the Philippines is significantly influenced by infections and feeding practices. Early intervention focusing on prenatal care, breastfeeding, and disease control is crucial for preventing growth retardation and improving long-term health outcomes.

Area of Science:

  • Pediatrics
  • Public Health
  • Nutrition Science

Background:

  • Childhood stunting is a significant public health concern with long-term consequences.
  • Understanding age-specific risk factors is essential for effective prevention strategies.

Purpose of the Study:

  • To identify age-specific factors associated with new stunting cases in Filipino children from birth to 24 months.
  • To inform targeted interventions for stunting prevention.

Main Methods:

  • Utilized data from the Cebu Longitudinal Health and Nutrition Survey (nearly 3000 participants).
  • Employed a multivariate discrete time hazard model to analyze bimonthly collected data on length, morbidity, feeding, and health.
  • Defined stunting as length >2 SD below WHO age- and sex-specific medians.

Main Results:

  • Stunting affected 69% of rural and 60% of urban children by 24 months.
  • Diarrhea, respiratory infections, early supplemental feeding, and low birth weight increased stunting likelihood.
  • Breastfeeding, preventive healthcare, and taller maternal stature decreased stunting likelihood.
  • Sex-specific patterns emerged: males more prone in the first year, females in the second.

Conclusions:

  • Stunting is strongly linked to impaired intellectual development and reduced adult stature.
  • Prevention requires promoting prenatal care, breastfeeding, and controlling infectious diseases.
  • Targeted, age-specific interventions are necessary to combat childhood stunting effectively.

Related Concept Videos

Polygenic Traits01:18

Polygenic Traits

When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...